Integrating leading-edge computational and experimental science to transform human health. $RLAY
Cambridge, MA
Joined March 2016
- Tweets734
- Following322
- Followers2.5K
- Likes321
Relay Therapeutics retweeted
Imogen Pryce joined @Relay_Tx in January 2019. She was tasked with helping the company get off the single Kendall Square floor where, for two years, they developed new tech to let scientists watch proteins as they moved.
endpts.com/the-201-under-40-…
Relay Therapeutics retweeted
Last but certainly not least are the nominees in the Life Science Deal/Exit of the Year category. The companies are Black Diamond Therapeutics, Exonics Therapeutics, @KymeraTx, @momentapharma, @Relay_Tx, Semma Therapeutics, and @MorphicTx. Congratulations! #NEVYsOz
Relay Therapeutics retweeted
our team @Relay_Tx is hiring a research software engineer to work on problems at the intersection of chemical physics and machine learning. perks: open source friendly, somewhat hard math problems, prospective validation, play with jax + more: bit.ly/2Y4WY2c
Relay Therapeutics retweeted
Congratulations to the @Relay_Tx team on today's IPO! GV's @kyeshwant reflects on the company's milestone – gv.com/news/relay-therapeuti…
Relay Therapeutics retweeted
With the #COVID19 pandemic & many unknowns, employees are dealing with increasing amounts of stress. Tomorrow's forum will share insight on what resources & programs are available, building awareness & comfort, utilizing those resources, & more bit.ly/3f4BlpG
Relay Therapeutics retweeted
New blog post at Practical Cheminformatics with a contribution from Brian Cole, "Adding Chemical Structures to a Recent COVID-19 Drug Repurposing Dataset", practicalcheminformatics.blo…
Relay Therapeutics retweeted
We’re excited to announce the appointment of Laura Shawver, Ph.D., as Silverback Therapeutics’ new President & CEO!
Dr. Shawver brings a strong track record as a scientist, biotech leader and patient advocate to the role. Meet Laura & learn more: bwnews.pr/2xQZtv9.
Relay Therapeutics retweeted
New blog post, with code, at Practical Cheminformatics, Building on the Fragments From the Diamond/XChem SARS-CoV-2 Main Protease (MPro) Fragment Screen (Part II) Structure-Base Evaluation of Expanded Fragments, practicalcheminformatics.blo…
Relay Therapeutics retweeted
Today we're introducing the GV Impact List: celebrating 25 outstanding women, nominated by CEOs, who have made a difference to their company's culture, innovation, and success – gv.com/impact #InternationalWomensDay #IWD2020
Relay Therapeutics retweeted
Today is #RareDiseaseDay 2020, the rarest day if the year!
How will you raise awareness today for people living with a rare disease and their families?
rarediseaseday.org/page/news…
Relay Therapeutics retweeted
We are excited to highlight Pat Walters (@wpwalters), SVP of Computation at @Relay_Tx, as a featured speaker at the MIT AIDM Conference 🗣
Check out his most recent blog post titled "AI in Drug Discovery - A Practical View From the Trenches" here: bit.ly/2PDImlp
Relay Therapeutics retweeted
Portfolio company job of the week: Director, Clinical Operations at @Relay_Tx (Cambridge, MA) – jobs.lever.co/relaytx/9b4e4f…
Relay Therapeutics retweeted
Scientists at the Movies. Listen to @SanjivKPatel1 of @Relay_Tx on the growing opportunity in computational chemistry for drug discovery. timmermanreport.com/2020/01/…
Relay Therapeutics retweeted
With its first program due to enter the clinic this year, @Relay_Tx will test its hypothesis that characterizing full-length protein targets across a range of conformations leads to better therapeutic candidates buff.ly/2RH9lh1
Relay Therapeutics retweeted
Psyched to see our paper "Rethinking drug design in the artificial intelligence era" in Nature Reviews Drug Discovery nature.com/articles/s41573-0…
Relay Therapeutics retweeted
This includes Merck alum Iain Martin who know joins its leadership team: fiercebiotech.com/biotech/re…
Relay Therapeutics retweeted
What is the real penetration of AI in the pharmaceutical industry?
This topic will be discussed by pioneers in AI implementation: @allg00d (@Numerate_Inc), Hugo Ceulemans (Janssen), Ola Engkvist (@AstraZeneca), Miriam Mathea (@BASF), @wpwalters (@Relay_Tx), Lee Herman(@Sunovion)
